Abstract
Northstar-2: Updated Safety and Efficacy Analysis of Lentiglobin Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia and Non-β0/β0 Genotypes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have